Skip to content
Delayed ~15 min

AMPH AMPHASTAR PHARMACEUTICALS

Health Care · Russell 2000

Next earnings: not announced yet

What 8 analyst firms say about AMPHASTAR PHARMACEUTICALS: their latest ratings, price targets and how far the stock is from them. How it works

28.49 USD+0.83 (+3.00%) today
Price as of 6 Nov 16:00 ET

Analyst window: Latest analyst report within last 1 year

Analyst view · last 1Y

−26.3%to the avg target 21.00 USD−7.49 USD
Buy 0 · Hold 6 · Sell 1

7 rated views · 8 analyst/firm records · 8 firms

Latest report2 Sep 2026avg report date 16 Jul
Target rangePrice is above every target

Radar score

  • Russell 2000 · Top Picks · 6MNot scored · Average target is not above the current price
  • Russell 2000 · Safest consensus · 6MNot scored · Average target is not above the current price

Recent analyst activity · last 90 days

Our tracked history has 3 reports on AMPH from 3 analyst firms in the last 90 days (8 firms in the past year).

Comparing each firm's latest target with its previous one: 1 raised its price target and 1 left it unchanged.

No firm's latest available rating differs from its previous one.

Latest observed target change: Barclays raised its target from $20.00 (set 3 Jun 2026) to $23.00 on 18 Aug 2026.

Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.

FirmAnalystLatest ratingReport dateLatest target (USD)
Bank of America SecuritiesJason GerberrySell29 Jun 202620.00 USD
BarclaysGlen SantangeloHold18 Aug 202623.00 USD
JefferiesDennis DingHold21 Apr 202622.00 USD
NeedhamSerge BelangerHold8 May 2026—
Piper SandlerDavid AmsellemHold7 Aug 202620.00 USD
Weiss RatingsUnnamed analyst—16 Oct 2026—
Wells FargoBenjamin BurnettHold2 Sep 202620.00 USD
Data feed RESEARCHResearch TeamHold21 Jul 2026—

Partial coverage · checked 6 Nov (6 Nov 2026, 06:09 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.